Fixed long-acting combinations of both anticholinergic and beta-agonist bronchodilators, not previously available, have been developed. A new fixed combination of glycopyrronium and indacaterol has ...
Treatment is therefore directed toward relief of symptoms and a reduction in the incidence of acute exacerbations. Within the past decade, major advances in management have been made in the ...
A study of older patients with chronic obstructive pulmonary disease (COPD) suggests that new use of the long-acting bronchodilators β-agonists and anticholinergics was associated with similar ...
Researchers find a 28 percent greater risk of heart attack and stroke in older patients taking commonly prescribed drugs for chronic obstructive pulmonary disease (COPD). Canadian scientists are ...
ANORO™ ELLIPTA™ approved as first once-daily dual bronchodilator for the treatment of COPD in the US
GlaxoSmithKline plc (LSE/NYSE: GSK) and Theravance, Inc. (NASDAQ: THRX) today announced that the US Food and Drug Administration (FDA) has approved ANORO™ ELLIPTA ...
Patients with COPD also have a high prevalence of CVD. Bronchodilators prescribed for symptomatic COPD control may also contribute to cardiovascular risk. In accordance with treatment guidelines, most ...
Scientists have long found a possible link between anticholinergic drugs and an increased risk of dementia. A study published in the journal JAMA Internal Medicine on Monday suggests that the link is ...
Inhalers prescribed for serious lung disease may increase the risk of deadly heart problems, say researchers. Trials on more than 15,000 patients found inhaled anticholinergic drugs increased the risk ...
Having the urge to urinate -- and not being able to do so -- is painful, as many men know. Now a study suggests that certain medications may make the emergency form of this condition, known as acute ...
LONDON--(BUSINESS WIRE)--According to the latest market study released by Technavio, the global bronchodilators market is expected to grow at a CAGR of close to 5% during the forecast period. This ...
A study of older patients with chronic obstructive pulmonary disease (COPD) suggests that new use of the long-acting bronchodilators β-agonists and anticholinergics was associated with similar ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results